What is NDC 62135-272?

62135-272 is the product NDC for Ramipril, Ramipril 2.5 mg/1 capsule, listed with the FDA by Chartwell RX, LLC.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Chartwell RX, LLC., NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ramipril?

67 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ramipril NDC 62135-272 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-272Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0272Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62135-272-01	62135027201	100 CAPSULE in 1 BOTTLE (62135-272-01)Marketed from Aug 26, 2020
62135-272-05	62135027205	500 CAPSULE in 1 BOTTLE (62135-272-05)Marketed from Aug 26, 2020
62135-272-90	62135027290	90 CAPSULE in 1 BOTTLE (62135-272-90)Marketed from Jan 2, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ramipril
Generic name (nonproprietary): ramipril
Active ingredients: Ramipril — 2.5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Chartwell RX, LLC.NDC labeler code 62135
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078745
Marketing start: Aug 26, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 62135-272_47ce17ad-f085-8ce7-e063-6294a90a7520SPL ID 47ce17ad-f085-8ce7-e063-6294a90a7520SPL set ID b7e49f05-6d4f-465a-b0d7-f704466a2e52RxCUI 198188, 198189, 261962, 845488UNII L35JN3I7SJUPC 0362135273903, 0362135272906, 0362135271909
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135027201 followed by a unit qualifier and the quantity

Package 62135-0272-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 7, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It may be used alone or in combination with thiazide diuretics ( 1.1 ). Ramipril capsules are indicated in stable patients who have demonstrated clinical signs of congestive heart failure post-myocardial infarction ( 1.3 ). 1.1 Hypertension Ramipril capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primaril…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62135-272

What is NDC 62135-272?: 62135-272 is the product NDC for Ramipril, Ramipril 2.5 mg/1 capsule, listed with the FDA by Chartwell RX, LLC.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ramipril.
What is the active ingredient?: Ramipril.
Who is the labeler?: Chartwell RX, LLC., NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ramipril?: 67 other product NDCs are listed under this name. See all Ramipril NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ramipril NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ramipril	Ramipril 2.5 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4604	70518-4604-00
Ramipril	Ramipril 5 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4607	70518-4607-00
Ramipril	Ramipril 2.5 mg/1	CapsuleOral	GSMS, Incorporated	51407-707	51407-0707-01
Ramipril	Ramipril 5 mg/1	CapsuleOral	GSMS, Incorporated	51407-708	51407-0708-01
Ramipril	Ramipril 10 mg/1	CapsuleOral	GSMS, Incorporated	51407-709	51407-0709-01
Ramipril	Ramipril 10 mg/1	CapsuleOral	Northwind Health Company, LLC	51655-904	51655-0904-2651655-0904-52
Ramipril	Ramipril 2.5 mg/1	CapsuleOral	Northwind Health Company, LLC	51655-975	51655-0975-52
Ramipril	Ramipril 5 mg/1	CapsuleOral	Northwind Health Company, LLC	51655-296	51655-0296-52
Ramipril	Ramipril 10 mg/1	CapsuleOral	Northwind Health Company, LLC	51655-406	51655-0406-52
Ramipril	Ramipril 10 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-3038	70518-3038-00

All 68 Ramipril NDCs

Other NDCs under ANDA 078745

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078745
Product	Strength	Form · route	Labeler	Product NDC
Ramipril	Ramipril 1.25 mg/1	CapsuleOral	Chartwell RX, LLC.	62135-271
Ramipril	Ramipril 5 mg/1	CapsuleOral	Chartwell RX, LLC.	62135-273
Ramipril	Ramipril 10 mg/1	CapsuleOral	Chartwell RX, LLC.	62135-274